Register Cart 0

Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back Subscribe

Subject Index To Volume 3

Author(s):

Volume 4, Issue 1, 2003

Page: [87 - 89] Pages: 3

DOI: 10.2174/1389201033378002

Price: $65

« Previous

Rights & Permissions Print Cite

Article Metrics

10

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Application of Sterylglucoside-Containing Particles for Drug Delivery
Current Pharmaceutical Biotechnology

Challenge of Mesenchymal Stem Cells Against Diabetic Foot Ulcer
Current Stem Cell Research & Therapy

Influence of Impaired Liver Methionine Metabolism on the Development of Vascular Disease and Inflammation
Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Targeting Vascular Niche by Parathyroid Hormone
Current Medicinal Chemistry

Recent Advances in Peptide-Based Approaches for Cancer Treatment
Current Medicinal Chemistry

The Role of PEDF in Tumor Growth and Metastasis
Current Molecular Medicine

Antiangiogenic Therapeutic Approaches in Multiple Myeloma
Current Cancer Drug Targets

Novel Reactions in the Cephalostatin Series
Current Organic Chemistry

Frontier View on Nanotechnological Strategies for Neuro-therapy
Current Drug Metabolism

Acute Pain Management in Hospitalized Children
Reviews on Recent Clinical Trials

Fumitremorgins and Relatives – From Tremorgenic Compounds to Valuable Anti-Cancer Drugs
Current Medicinal Chemistry

Graphical Abstracts
Letters in Drug Design & Discovery

Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry

On the Search for Skin Gene Therapy Strategies of Xeroderma Pigmentosum Disease
Current Gene Therapy

Liposomes as Vehicles for Enhancing Drug Delivery Via Skin Routes
Current Nanoscience

Prediction of the Estrogen Receptor Binding Affinity for both hER<sub>α</sub> and hER<sub>β</sub> by QSAR Approaches
Letters in Drug Design & Discovery

Recent Trends on the Use of Nanoparticles for Nitric Oxide Delivery in Antimicrobial Applications
Drug Delivery Letters

HER3 and its Ligand, Heregulin, as Targets for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery

Anti-IL-12/23 in Crohn's Disease: Bench and Bedside
Current Drug Targets

OX40:OX40L Axis: Emerging Targets for Immunotherapy of Human Disease
Current Immunology Reviews (Discontinued)

© 2025 Bentham Science Publishers | Privacy Policy